These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 32386751

  • 1. Effects of dipeptidyl peptidase 4 inhibition on inflammation in atherosclerosis: A 18F-fluorodeoxyglucose study of a mouse model of atherosclerosis and type 2 diabetes.
    Virta J, Hellberg S, Liljenbäck H, Ståhle M, Silvola JMU, Huusko J, Söderström M, Knuuti J, Nuutila P, Ylä-Herttuala S, Gomez MF, Roivainen A, Saraste A.
    Atherosclerosis; 2020 Jul; 305():64-72. PubMed ID: 32386751
    [Abstract] [Full Text] [Related]

  • 2. Effects of atorvastatin and diet interventions on atherosclerotic plaque inflammation and [18F]FDG uptake in Ldlr-/-Apob100/100 mice.
    Hellberg S, Sippola S, Liljenbäck H, Virta J, Silvola JMU, Ståhle M, Savisto N, Metso J, Jauhiainen M, Saukko P, Ylä-Herttuala S, Nuutila P, Knuuti J, Roivainen A, Saraste A.
    Atherosclerosis; 2017 Aug; 263():369-376. PubMed ID: 28457625
    [Abstract] [Full Text] [Related]

  • 3. Effects of age, diet, and type 2 diabetes on the development and FDG uptake of atherosclerotic plaques.
    Silvola JM, Saraste A, Laitinen I, Savisto N, Laine VJ, Heinonen SE, Ylä-Herttuala S, Saukko P, Nuutila P, Roivainen A, Knuuti J.
    JACC Cardiovasc Imaging; 2011 Dec; 4(12):1294-301. PubMed ID: 22172786
    [Abstract] [Full Text] [Related]

  • 4. No pleotropic effects of linagliptin on atherosclerotic plaques: Case closed.
    Al-Mallah MH, Hyafil F, Santulli G.
    Atherosclerosis; 2020 Jul; 305():61-63. PubMed ID: 32561072
    [No Abstract] [Full Text] [Related]

  • 5. Type 2 diabetes enhances arterial uptake of choline in atherosclerotic mice: an imaging study with positron emission tomography tracer ¹⁸F-fluoromethylcholine.
    Hellberg S, Silvola JM, Kiugel M, Liljenbäck H, Metsälä O, Viljanen T, Metso J, Jauhiainen M, Saukko P, Nuutila P, Ylä-Herttuala S, Knuuti J, Roivainen A, Saraste A.
    Cardiovasc Diabetol; 2016 Feb 06; 15():26. PubMed ID: 26852231
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of inflammation-mediated DPP-4 expression by linagliptin increases M2 macrophages in atherosclerotic lesions.
    Nishida S, Matsumura T, Senokuchi T, Murakami-Nishida S, Ishii N, Morita Y, Yagi Y, Motoshima H, Kondo T, Araki E.
    Biochem Biophys Res Commun; 2020 Mar 26; 524(1):8-15. PubMed ID: 31964532
    [Abstract] [Full Text] [Related]

  • 7. Imaging of atherosclerotic aorta of rabbit model by detection of plaque inflammation with fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography.
    Zhao QM, Feng TT, Zhao X, Xu ZM, Liu Y, Li DP, Li LQ, Su G, Zhang XX.
    Chin Med J (Engl); 2011 Mar 26; 124(6):911-7. PubMed ID: 21518602
    [Abstract] [Full Text] [Related]

  • 8. Effect of the dipeptidyl peptidase-4 inhibitor linagliptin on atherosclerotic lesions in Watanabe heritable hyperlipidemic rabbits: iMap-IVUS and pathological analysis.
    Kurosawa T, Li Y, Sudo M, Haruta H, Hagikura K, Takayama T, Hiro T, Shiomi M, Hao H, Matsumoto T, Hirayama A, Okumura Y.
    Heart Vessels; 2021 Jan 26; 36(1):127-135. PubMed ID: 32914346
    [Abstract] [Full Text] [Related]

  • 9. [18F]fluorodeoxyglucose uptake in atherosclerotic plaques is associated with reduced coronary flow reserve in mice.
    Uotila S, Silvola JM, Saukko P, Nuutila P, Heinonen SE, Ylä-Herttuala S, Roivainen A, Knuuti J, Saraste A.
    J Ultrasound Med; 2014 Nov 26; 33(11):1941-8. PubMed ID: 25336481
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Exploiting Glutamine Consumption in Atherosclerotic Lesions by Positron Emission Tomography Tracer (2S,4R)-4-18F-Fluoroglutamine.
    Palani S, Miner MWG, Virta J, Liljenbäck H, Eskola O, Örd T, Ravindran A, Kaikkonen MU, Knuuti J, Li XG, Saraste A, Roivainen A.
    Front Immunol; 2022 Nov 26; 13():821423. PubMed ID: 35145523
    [Abstract] [Full Text] [Related]

  • 12. DPP-4 Inhibition by Linagliptin Attenuates Obesity-Related Inflammation and Insulin Resistance by Regulating M1/M2 Macrophage Polarization.
    Zhuge F, Ni Y, Nagashimada M, Nagata N, Xu L, Mukaida N, Kaneko S, Ota T.
    Diabetes; 2016 Oct 26; 65(10):2966-79. PubMed ID: 27445264
    [Abstract] [Full Text] [Related]

  • 13. The Dipeptidyl Peptidase-4 Inhibitor Linagliptin Ameliorates High-fat Induced Cognitive Decline in Tauopathy Model Mice.
    Nakaoku Y, Saito S, Yamamoto Y, Maki T, Takahashi R, Ihara M.
    Int J Mol Sci; 2019 May 23; 20(10):. PubMed ID: 31126115
    [Abstract] [Full Text] [Related]

  • 14. Peroxisome proliferator-activated receptor-alpha activation and dipeptidyl peptidase-4 inhibition target dysbiosis to treat fatty liver in obese mice.
    Silva-Veiga FM, Miranda CS, Vasques-Monteiro IML, Souza-Tavares H, Martins FF, Daleprane JB, Souza-Mello V.
    World J Gastroenterol; 2022 May 07; 28(17):1814-1829. PubMed ID: 35633911
    [Abstract] [Full Text] [Related]

  • 15. Combined PET/DCE-MRI in a Rabbit Model of Atherosclerosis: Integrated Quantification of Plaque Inflammation, Permeability, and Burden During Treatment With a Leukotriene A4 Hydrolase Inhibitor.
    Calcagno C, Lairez O, Hawkins J, Kerr SW, Dugas MS, Simpson T, Epskamp J, Robson PM, Eldib M, Bander I, K-Raman P, Ramachandran S, Pruzan A, Kaufman A, Mani V, Ehlgen A, Niessen HG, Broadwater J, Fayad ZA.
    JACC Cardiovasc Imaging; 2018 Feb 07; 11(2 Pt 2):291-301. PubMed ID: 29413439
    [Abstract] [Full Text] [Related]

  • 16. Linagliptin improves insulin sensitivity and hepatic steatosis in diet-induced obesity.
    Kern M, Klöting N, Niessen HG, Thomas L, Stiller D, Mark M, Klein T, Blüher M.
    PLoS One; 2012 Feb 07; 7(6):e38744. PubMed ID: 22761701
    [Abstract] [Full Text] [Related]

  • 17. Monitoring plaque inflammation in atherosclerotic rabbits with an iron oxide (P904) and (18)F-FDG using a combined PET/MR scanner.
    Millon A, Dickson SD, Klink A, Izquierdo-Garcia D, Bini J, Lancelot E, Ballet S, Robert P, Mateo de Castro J, Corot C, Fayad ZA.
    Atherosclerosis; 2013 Jun 07; 228(2):339-45. PubMed ID: 23582588
    [Abstract] [Full Text] [Related]

  • 18. Quantification of inflammation within rabbit atherosclerotic plaques using the macrophage-specific CT contrast agent N1177: a comparison with 18F-FDG PET/CT and histology.
    Hyafil F, Cornily JC, Rudd JH, Machac J, Feldman LJ, Fayad ZA.
    J Nucl Med; 2009 Jun 07; 50(6):959-65. PubMed ID: 19443582
    [Abstract] [Full Text] [Related]

  • 19. Anagliptin, a dipeptidyl peptidase-4 inhibitor, decreases macrophage infiltration and suppresses atherosclerosis in aortic and coronary arteries in cholesterol-fed rabbits.
    Hirano T, Yamashita S, Takahashi M, Hashimoto H, Mori Y, Goto M.
    Metabolism; 2016 Jun 07; 65(6):893-903. PubMed ID: 27173468
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of alphavbeta3 integrin-targeted positron emission tomography tracer 18F-galacto-RGD for imaging of vascular inflammation in atherosclerotic mice.
    Laitinen I, Saraste A, Weidl E, Poethko T, Weber AW, Nekolla SG, Leppänen P, Ylä-Herttuala S, Hölzlwimmer G, Walch A, Esposito I, Wester HJ, Knuuti J, Schwaiger M.
    Circ Cardiovasc Imaging; 2009 Jul 07; 2(4):331-8. PubMed ID: 19808614
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.